The following symptoms warrant prompt medical attention and patients should contact their GP or seek urgent care if they experience: Severe or persistent abdominal pain , which may indicate pancreatitis a recognised risk with GLP-1-containing therapies [13] Jaundice, right upper quadrant pain, or fever , which may suggest gallbladder disease Signs of dehydration or reduced kidney function , such as dizziness, markedly reduced urine output, or confusion, particularly if vomiting or diarrhoea is prolonged Visual changes , particularly in individuals with pre-existing diabetic retinopathy Patients taking retatrutide alongside insulin or a sulfonylurea should be aware of an increased risk of hypoglycaemia (low blood sugar)
Optic Labs supplies retatrutide for laboratory research only not for human consumption, clinical use, or any therapeutic application
A: Slightly more effective (15-22% vs 15-17% weight loss)
Treatment for confirmed B12 deficiency includes oral cyanocobalamin for dietary causes or intramuscular hydroxocobalamin for malabsorption or neurological involvement, following NHS and BNF guidance